Name: Destruction of breast cancer cells by a phytochemical, Artonin E (en Inglés)
Price: 104270.00 CLP
Availability: InStock
Author: Etti, Imaobong ; Abdullah, Rasedee ; Hashim, Najihah
ISBN: 9786200479983

portada Destruction of breast cancer cells by a phytochemical, Artonin E (en Inglés)

Formato

Libro Físico

Autor

Imaobong Etti

Rasedee Abdullah

Najihah Hashim

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

148

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.9 cm

Peso

0.23 kg.

ISBN13

9786200479983

Categorías

Cuestiones generales de la medicina

Destruction of breast cancer cells by a phytochemical, Artonin E (en Inglés)

Imaobong Etti (Autor) · Rasedee Abdullah (Autor) · Najihah Hashim (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo

$ 104.270

$ 144.820

Ahorras: $ 40.550

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 08 de Agosto y el Martes 20 de Agosto.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Destruction of breast cancer cells by a phytochemical, Artonin E (en Inglés)"

The destruction of breast cancer cells by a phytochemical, Artonin E is a book for students, researchers and for all concerned with evidence-based therapeutic management of breast cancer using natural product. This research was borne out of a deep passion to subdue the global menace of breast cancer. The resistance and high toxicity ensuing from modern breast cancer treatment regimens have reduced the survival rate, causing most cancer patients to seek natural remedies with fewer side-effects as alternatives. Artonin E, is a naturally occurring prenylated flavonoid, reported to possess a wide spectrum of in vitro biological activities. This book utilizes a rational approach in drug discovery and development to unravel the cancer inhibitory potential of this phytochemical, Artonin E. Embracing the advances in computational biology, it employed in silico models to predict the drug-likeness of this promising compound in comparison to similar analogues as well as its effect on the popular human estrogen receptor α (hER α) which drives the majority of reported breast cancer cases. As reported herein, this compound is a promising sledge hammer needed to fight breast cancer.